- [PRESSWIRE] Parma, Italy – April 9, 2020 — The ERA-EDTA has established a European database that collects granular data of individual dialysis patients and transplanted patients with COVID-19. The hope is to achieve insights into patient and treatment characteristics that are related to outcome and to learn about modifiable risk factors, which would help to improve prognoses.
- [PRESSWIRE] Reykjavik, Iceland – 26 March 2020 — The first Coronavirus Medical Express flight departs Shanghai at 23:30 GMT today airlifting urgently needed supplies to fight the coronavirus from China to Europe.
- [PRESSWIRE] 19.03.20 – Chicago, IL. – Surgisphere ha sviluppato uno strumento per il triage del COVID-19 che aiuta a gestire le priorità nelle cure per i pazienti in urgente stato di necessità.
- [PRESSWIRE] Chicago, IL United States – 19 March, 2020 — Surgisphere has developed a COVID-19 triage tool that helps prioritize care for patients who are in urgent need of care.
- [PRESSWIRE] Parma, Italy – March 12, 2020 — Kidney involvement seems to be frequent in patients who have tested positive for coronavirus. Acute kidney injury might be a predictor of mortality in infected patients.
- [PRESSWIRE] Parma, Italy – 11 March, 2020 – Dialysis centers should not be tipped into panic but need to adopt common sense precautions. ERA-EDTA has therefore published a set of guidelines recommending several well-balanced measures to dialysis centers.
- [PRESSWIRE] Parma, February 26, 2020 – Study shows that patients older than 75 years who received a kidney from a similarly aged donor remain dialysis-free for the rest of their lives!
- [PRESSWIRE] 29 January, 2020 – UK — New research released today reveals that the average football fan in the United States, will eat a staggering 10,821 calories and 180 grams of saturated fat this Super Bowl Sunday.
- [PRESSWIRE] Atlanta, Ga. – 14 gennaio 2020 — Il Team Novo Nordisk, la prima squadra ciclistica professionistica al mondo interamente composta da corridori con diabete, correrà la stagione 2020 su telai Colnago completi di componenti, freni a disco e misuratori di potenza Shimano di2, indossando kit progettati dalla GSG.
- [PRESSWIRE] Atlanta, Ga. – 14 January, 2020 —Team Novo Nordisk, the world’s first all-diabetes pro cycling team, will race the 2020 season on Colnago frames complete with Shimano di2 components, disc brakes, and power meters while wearing GSG-designed kits.
- [PRESSWIRE] UK – 10 January, 2020 — To coincide with Blue Monday on January 20th, electronics retailer Ebuyer has conducted a survey into the link between mental health and online help.
- [PRESSWIRE] Parma – December 19, 2019 — The 2017 Annual Report of the ERA-EDTA Registry [1] reveals that only a small fraction of patients accepted for renal replacement therapy are able to start this treatment with the best available therapy, which is transplantation, – and that the number of people who are in need of renal replacement therapy is rising. This poses a major challenge to our health systems, therefore everything should be done to fight this trend, e.g. by strengthening prevention.
- [PRESSWIRE] Parma, November – 18, 2019 — High protein intake is believed to be healthy, but it may pave the way to irreversible kidney failure. The risk of the kidneys being harmed by a diet rich in proteins is especially high in people with a pre-existing low-grade chronic kidney disease, of which most of the affected people are unaware. “It is essential that people know there is another side to high-protein diets.”
- [PRESSWIRE] BOSTON, Nov. 18, 2019 — Biofourmis, a fast-growing global leader in digital therapeutics based in Boston, announced today it has been selected by Novartis, a global healthcare company, to collaborate on a commercial project for managing patients with heart failure (HF) beginning in Southeast Asia, with potential plans to expand globally. The goal of the program is to improve clinical outcomes by using Biofourmis’ lead product BiovitalsHF™, which captures data from wearable biosensors and leverages the FDA-cleared Biovitals™ Analytics Engine to identify early signs of HF exacerbations to enable early interventions in patients with HF with reduced ejection fraction.
- [PRESSWIRE] Parma – November 12, 2019 – Diabetes is one of the key drivers of chronic kidney disease and the most frequent reason why patients are in need of renal replacement therapy. Conversely, outcomes for dialysis patients with diabetes are rather poor. For these reasons, the ERA-EDTA aims to raise awareness of the threat of kidney disease on World Diabetes Day on November 14. It is important to prevent diabetes wherever possible and if not, to take great care to ensure that kidney health is protected in diabetic patients. SGLT2 inhibitors have the potential to treat CKD in patients with diabetes.
- [PRESSWIRE] DENVER, Oct. 24, 2019 — Aspen Laser Systems, LLC, an emerging leader in laser therapy, also referred to as Photobiomodulation, announced that it has been recognized with an award by Global Health & Pharma, a leading publication and information sharing platform, dedicated to the healthcare industry.
- [PRESSWIRE] ITALY – 15 October, 2019 — The 18th Congress of the International Pediatric Nephrology Association (IPNA) will take place in Venice, Italy, from 17-21 October 2019. IPNA’s vision is to achieve optimal care for all children with kidney disease all over the world through advocacy, education, and training in developed countries as well as in under-resourced regions. By means of the Congress and various educational programs, IPNA disseminates knowledge in order to improve the situation of more than 23,000 children on chronic renal replacement therapy.
- [PRESSWIRE] LONDON, July 29, 2019 — In 2018, the urology devices market is estimated at $6.9bn and is expected to grow at a CAGR of 6.1% from 2018 to 2029. The urinary incontinence market dominated the market in 2018 and accounted for 33.8% of the urology devices market.
- [PRESSWIRE] London – 09 July 2019 — The exclusion of patients with kidney diseases from clinical trials remains an unsolved problem that hinders optimal care of these patients. Over 850 million people suffer from kidney diseases worldwide, a number which signifies epidemic proportions, yet these patients are still ignored by investigators and initiators of clinical trials in all medical fields – and are thus excluded from clinical trials. ASN, ERA-EDTA and ISN, collaboratively aim to bring about a paradigm change in medical research and have launched an information campaign to that end.
- [PRESSWIRE] SEATTLE, June 19, 2019 — Bardy Diagnostics, Inc., (“BardyDx”), a leading provider of ambulatory cardiac monitoring technologies and custom data solutions, announced that MedTech Innovator, the premier nonprofit startup accelerator in the medical technology industry, has selected BardyDx to participate in the organization’s 2019 Showcase program, featuring the most promising medical technologies from around the globe.
- [PRESSWIRE] Budapest – June 14, 2019 — Kidney transplantation is the treatment of choice for most people with kidney failure, as it will improve their survival while increasing their quality of life compared to remaining on dialysis.
- [PRESSWIRE] Budapest – June 14, 2019 — In the CARMELINA trial nearly 10% of all patients with diabetes had nephrotic-range proteinuria at baseline. This was associated with a high incidence of cardiovascular/kidney disease but this secondary disease burden could not be lowered by linagliptin.
- [PRESSWIRE] Budapest – June 14, 2019 — 26% of patients had been employed 6 months prior to dialysis initiation – but this dropped to 15% when dialysis treatment was initiated.
- [PRESSWIRE] Budapest, June 14, 2019 – As chronic kidney disease (CKD) progresses, the kidneys become less able to maintain a healthy balance of acids in the body, a condition known as metabolic acidosis.
- [PRESSWIRE] Budapest – June 14, 2019 — Epidemiological and clinical research and public policy in Europe are generally considered to be comprehensive and successful – and the European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) is playing a key role in the field of nephrology research.
- [PRESSWIRE] Budapest – June 14, 2019 — Acute kidney injury (AKI) is a common complication after cardiac surgery. The severity fluctuates from subclinical AKI, an increase in biochemical markers of kidney injury, to severe AKI requiring renal replacement therapy with dialysis.
- [PRESSWIRE] Budapest – June 13, 2019 — Alport syndrome (AS) is a hereditary type IV collagen disease that leads to progressive proteinuria, renal fibrosis, and kidney failure.
- [PRESSWIRE] Budapest – June 13, 2019 — High cardiovascular morbidity and mortality remain a persisting problem in patients with CKD. Many efforts have been made in subjects with normal kidney function to prevent and to reduce the progression of cardiovascular diseases.
- [PRESSWIRE] Budapest – June 13, 2019 — Historically, the number of RCTs performed in the ESRD population has been very low compared to other medical subspecialties. Furthermore, several of the few large RCTs conducted in patients with ESRD have yielded inconclusive or negative results, dampening enthusiasm for future investment in similar trials.
- [PRESSWIRE]10 June, 2019 – Vancouver, British Columbia — Harvest One (“Harvest One” or the “Company”) (TSXV: HVT; OTCQX: HRVOF), through it’s wholly-owned subsidiary Satipharm Ltd. (“Satipharm”) today announced that it has entered into an agreement to distribute their proprietary Satipharm CBD 10mg Gelpell® through Holland & Barrett, Europe’s largest retailer of nutritional supplements and wellness products with over 145 years of experience in the health and wellness industry.